INTRODUCTION
Hedgehog (Hh) is a signaling pathway implicated in fundamental processes during embryonic development, including regulation of cell fate, proliferation and differentiation (1) , consisting of diffusible morphogens, receptors, co-receptors and transduction factors (2) . The pathway is highly conserved in the evolution, but significant differences exist between invertebrates and vertebrates, where several of the pathway's components are apparently redundant (3) . Vertebrates have three Hh orthologs (Sonic, Indian and Desert) and two Patched receptors, and the functions of the intracellular effector Ci are shared among at least three proteins: Gli1, Gli2 and Gli3 (4) . Gli1 exclusively and Gli2 mostly act as activators. On the other hand, full-length Gli3 is an activator of transcription but it is turned into a short repressor form by a process that requires primary cilia (5) . It has been established that during kidney morphogenesis, the balance between activation and repression of the Hh pathway is determinant for the correct expression of kidney patterning genes: loss of Gli3 repressor activity results in severe defects in the number of nephrons (6, 7) , but the role of Hh pathway in the adult kidney has not been explored. GLIS2 is a putative vertebrate ortholog of Drosophila Ci, of which loss of function results in the development of cystic kidney disease and fibrosis in humans and mice (8, 9) . The high sequence similarity between Glis2 and the Gli proteins together with their common localization to primary cilia led us to hypothesize that Glis2 participates in the regulation of Hh signaling in kidney tubular cells. Here, we demonstrate that Glis2 is a regulator of Hh signaling and that its repressor activity is required after birth to conclude developmental programs and maintain tubular cells in a differentiated state. These effects are at least in part obtained by the transcriptional control that Glis2 exerts on the inducer of epithelial-to-mesenchymal transition (EMT) Snai1 and on the kidney developmental gene Wnt4. † These two authors contributed equally to the work. 
RESULTS

Glis2 is a functional component of the Hh signaling pathway
We performed semi-quantitative RT-PCR on mouse inner medullary collecting duct cells (IMCD3). mRNA transcripts encoding Glis2, Gli1, Ptch1 and Smo were abundant in this cell line, showing that IMCD3 cells express components of the Hh pathway (Fig. 1A ). Gli1 and Ptch1 expression increased when IMCD3 cells were grown in the presence of sonic hedgehog (Shh)-conditioned medium (Fig. 1B) , indicating that this renal epithelial cell line is responsive to Shh. Gli1, Gli2 and Gli3 mediate the intracellular transduction of Hh signaling in vertebrates (3) . Their activity is regulated, among other means, by the interaction with suppressor of fused (SuFu) (10, 11) . We have found that Glis2, like other GLI family members (12) , interacts with SuFu: native Glis2 can be co-precipitated with myc-SuFu overexpressed in HEK293T cells following immunoprecipitation with an anti-myc antibody but not by total IgG (Fig. 1C , left panels; see Materials and Methods and Supplementary Material, Fig. S1 , for the description of the custom-generated anti-Glis2 antibody TX747). In the reverse reaction, constitutive SuFu co-precipitated with overexpressed myc-tagged Glis2 (Fig. 1C, right panels) . To verify whether this interaction occurs in a more physiological context, we reciprocally co-precipitated endogenous Glis2 and SuFu using specific antibodies, confirming the interaction between the native proteins (Fig. 1D) . We also noticed that the fraction of SuFu and Glis2 that was co-precipitated was of higher molecular weight than the fraction detected in the lysates. We tested whether the shift in molecular weight depended on post-translational modification of these proteins: an anti-ubiquitin antibody reacted with the slow migrating band, indicating that the immunoprecipitated complex is ubiquitinated (Fig. 1E) . We also assayed whether Glis2 was subject to phosphorylation as other members of the Gli family: incubating the immunoprecipitate with calf intestinal phosphatase (CIP) resulted in a shift in the molecular weight of the immunoprecipitated Glis2 (Fig. 1F) , indicating that the fraction of Glis2 immunoprecipitated with SuFu is phosphorylated. Interestingly, the interaction of SuFu has been recently found to also regulate the proteasome-mediated cleavage of Gli3, another member of the Gli family (13) . Unfortunately, we were not able to verify whether Glis2 participates to this process because of the absence of an effective anti-Gli3 antibody.
Glis2 inhibits Gli1 activity in cultured renal epithelial cells in the postnatal kidney
Gli1 is a positive effector of Hh signaling, acting as a transcriptional activator. Gli1 recognizes specific consensus sequences (Gli-binding sequences, GBSs) in the promoters of several genes (14) . We previously showed that Glis2 can compete with Gli1 for binding to a GBS in a transcriptional assay in vitro (8) . Using lentiviral vectors, we stably expressed several different Glis2-targeting shRNAs, or anti-GFP shRNAs as negative controls, in IMCD3 cells. We found that Gli1 expression is strongly upregulated when Glis2 is suppressed in IMCD3 cells ( Fig. 2A and Supplementary Material, Fig. S2 ), indicating that Glis2 acts as a repressor of the Hh pathway. Hh signaling orchestrates the development of embryonic kidney (6, 7, 15) , and its activity is considerably reduced at birth when it becomes restricted to the renal medulla (15) . To 
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verify whether Hh activity persists later in life, we examined b-gal expression in kidneys of Gli1 +/lacZ mice at 4 weeks after birth. Gli1 +/lacZ mice were generated by in-frame insertion of the lacZ gene after the first exon of Gli1 and can be used as an in vivo readout of Hh function (16) . b-Gal activity was clearly detectable in the renal medulla of Gli1 +/lacZ mice ( Fig. 2B) but not in non-transgenic controls (Fig. 2C) . To exclude the possibility of an artifact, we compared the expression pattern of an unrelated gene, analyzing the kidneys of the Sirt6 +/lacZ transgenic mouse (17) . The distribution of b-gal in these two models was clearly different, with most of the signal in Gli1 +lacZ kidneys being concentrated in the interstitium and with only few positive tubular cells (Supplementary Material, Fig. S3A -D) , indicating the specificity of the reaction. As a further proof, we also tested b-gal activity in Gli1 +/lacZ kidneys at postnatal day 1 (Supplementary Material, Fig.  S3E ): we found that the distribution of b-gal overlapped with the expression of another known Hh target, the gene Ptch1, as previously reported by others (15) . All these results confirm that low levels of Hh activity are still present in the adult kidney after the development is fully completed. To verify whether Hh activity in the kidney is increased in the absence of Glis2 in vivo, we crossed Glis2 mut/mut mice (18) with Gli1 +/lacZ mice. At 4 weeks, Glis2 +/mut ;Gli1 +/lacZ double-heterozygous mice showed significant increase of b-gal expression ( Fig. 2D and E) . b-Gal activity was mostly observed in interstitial cells and more sparsely in the tubular compartment (Fig. 2F ). Since increased Gli1 activity results in the loss of markers of developed tubules, we could not unequivocally identify the segments expressing b-gal. The structures where the signal was more concentrated were tubules extending from the cortex to the medulla that are suggestive of collecting ducts, but b-gal was present at lower levels also in other segments (Fig. 2G ).
Glis2 maintains the differentiated epithelial phenotype by inhibiting the epithelial-to-mesenchymal inducer Snai1
Kidney tubular cells in Glis2-knockout mice express markers that are characteristic of the mesenchymal lineage (8) . To understand whether this phenotypic transformation is primarily due to a cell autonomous function of Glis2 in controlling cell differentiation, we further characterized the phenotype of Glis2-knockdown IMCD3 cells. Glis2 suppression in this Epithelial cells lost their typical cobblestone appearance, assumed a spindle shape, lost E-cadherin expression and expressed the mesenchymal marker S100A4/FSP-1 ( Fig. 3A and B). The cells also acquired migratory capacity, as shown by time-lapse imaging (Supplementary Material, Movies S1 and S2). Five different Glis2-targeting shRNAs were used to reduce the likelihood of off-target effects and all gave comparable results. Furthermore, we generated IMCD3 cells that were stably infected with constructs in which shRNA transcription was controlled by a doxycycline-inducible promoter (19) . Cells were exposed to doxycycline for 3 days and then returned to regular medium for an equal time. The increased expression of two Hh target genes, Snai1 and Wnt4, observed upon Glis2 silencing was reversed after doxycycline withdrawal (Fig. 3C ), indicating that the observed upregulation is consequent to Glis2 inactivation. These data suggest that the EMT observed in vivo is the result of an abnormal program triggered by the lack of Glis2 and not the consequence of organ damage. We next sought to determine whether Hh/ Gli1 overactivity was responsible for this effect. Treatment of Glis2-knockdown IMCD3 cells with the Gli inhibitor GANT58 (20) , resulted in a decrease of FSP-1 expression (Fig. 3D ), indicating that EMT is driven by Gli activators. EMT is normally observed during gastrulation, when cells migrate from the epithelial layers of the embryo to form the primitive mesenchyme (21) . The reciprocal process (mesenchymal-to-epithelial transformation, MET) occurs during normal kidney development, when metanephric mesenchymal cells become epithelial and give rise to the nephron (22) . Transcription factors, such as Snail, control EMT by inhibiting E-cadherin expression and inducing mesenchymal genes (23) . We previously found by microarray analysis that the transcription of the EMT inducer, Snai1, was upregulated in kidneys from Glis2-knockout mice compared with wildtype controls (8) . We measured Snai1 expression in IMCD3 Glis2-knockdown cells and found that Snai1 is upregulated at RNA and protein levels ( Fig. 4A and B) . To investigate how Glis2 affects the regulation of Snai1 transcription, we performed chromatin immunoprecipitation (ChIP) on IMCD3 cells using the anti-Glis2 antibody TX747 or total IgG as a control. We designed primers to obtain amplicons that Fig. S4A ). Importantly, no enrichment was detected with ChIP assays performed when Glis2 expression was silenced (IMCD3 7_2). To test whether this element affects the transcription of Snai1, we built two reporter vectors cloning the Snai1 core promoter alone or the core promoter preceded by the -5163 GBS, upstream of the firefly luciferase gene (Fig. 4E) . Luciferase activity was significantly reduced in the presence of the GBS (Fig. 4F ). To confirm that lack of Glis2 results in increased Snai1 expression also in vivo, we examined kidneys of Glis2 mut/mut mice using an anti-Snail-specific antibody and we found that Snai1 was expressed in straight tubular structures, with a distribution similar to what we observed for b-gal, in Glis2-knockout kidneys, compared with controls ( Fig. 4G) . Expression of Snai1 is known to increase under conditions of Gli1 overactivity (24) . Our data indicate that Glis2 exerts a negative feedback on Snai1 both indirectly, by inhibiting Gli1 expression, and directly by interacting with specific 5 ′ regulatory elements (8) . Collectively, these findings suggest that Hh drives the EMT observed in kidney tubular cells in the absence of Glis2 through upregulation of Snai1.
Glis2 represses the Hh-dependent expression of the developmental gene Wnt4
The abnormal persistence of embryonic developmental markers is observed in several models of cystic kidney disease (25, 26) . The definitive mammalian kidney (metanephro) develops as the result of the interaction between metanephric mesenchymal cells and the ureteric bud (27, 28) . The gene Wnt4 is expressed in the metanephric mesenchyme that condenses to form pretubular aggregates, and is downregulated after the fusion of the nephron precursors (vesicles, comma-shaped and S-shaped bodies) with the collecting ducts that are derived from the ureteric bud (29) . Microarrays showed that Wnt4 was upregulated in kidneys of Glis2 -/ -mice (8, 18) . We found that Wnt4 is also upregulated in expression microarrays performed on Glis2-knockdown IMCD3 cells compared with controls (data not shown). To further investigate the relationship between Glis2 and Wnt4, we first confirmed that Wnt4 expression is increased in Glis2-knockdown IMCD3 cells at protein (Fig. 5A ) and mRNA level (Fig. 5B) . Treatment with the Gli inhibitor GANT58 resulted in decreased Wnt4 expression, indicating that Wnt4 overexpression is mediated by Gli activators (Fig. 5C ). We then asked whether, in these cell lines, Glis2 regulates Wnt4 mut/mut and wild-type kidney obtained using an antibody against Snail. Snail is overexpressed in Glis2-knockout tubules reminiscent of collecting ducts (large dash) but not in structures resembling proximal/distal tubules (fine dash).
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transcription. By inspecting the genomic sequence upstream of Wnt4, we identified a putative GBS located at 21077 base pairs from the TTS (Fig. 5D and Supplementary Material, Table S1 ). ChIP using the TX747 anti-Glis2 antibody resulted in the enrichment of this GBS of about 15 times, as measured by real-time PCR (Fig. 5E and Supplementary Material, Fig.  S4B ). When this regulatory element was cloned upstream of the core promoter of Wnt4 (30) in a luciferase reporter vector, the transcription of the luciferase was reduced (Fig. 5F ), indicating that Glis2 directly modulates Wnt4 expression. Wnt4 is necessary for the development of the metanephric mesenchyme (29) . We hypothesized that the increased Wnt4 expression observed in kidney tubular cell lines in the absence of Glis2 could represent the de-differentiation of mature epithelial cells to an earlier mesenchymal stage.
To test this hypothesis, we examined another developmental marker, Pax2, a known Hh target during kidney development (6) and found that its expression was increased in Glis2-knockdown IMCD3 cells but not in the non-targeted controls (Fig. 6A, lanes 2 and 4) . Pax2 expression was also upregulated in Glis2 mut/mut kidneys, as shown by immunofluorescence confocal microscopy ( Fig. 6B and C) . Treating Glis2-knockdown cells with GANT58 resulted in Pax2 reduced expression, indicating that the observed effect is mediated by Gli activity (Fig. 6A, lanes 1 and 3) . Taken together, these results indicate that Glis2 is an inhibitor of the Hh pathway in kidney tubular cells. Since Hh activity is downregulated after birth, we would expect Glis2 expression to rise in the kidney with the completion of the maturation. We quantified the transcription of Glis2 at several intervals after birth by real-time PCR and compared it with the expression of other Gli genes. We observed opposite expression patterns of Glis2 compared with Gli1, Gli2 and Gli3, at different time points after birth (Fig. 6D) , suggesting that Glis2 is one of the factors that concur to the downregulation of Hh signaling in the postnatal kidney.
DISCUSSION
In this study, we have investigated the participation of Glis2 in Hh signaling, how its absence alters this pathway and the effects that result from Hh misregulation in the postnatal kidney. The data we have presented provide for the first time evidence that Glis2 is a repressor of the Hh pathway and that Hh/Gli signaling persists with minimal activity in fully developed kidneys. We base the conclusion that Glis2 participates in the Hh pathway on the results of biochemical and functional experiments. We show by several means that suppression of Glis2 in cultured cells is accompanied by a significant increase of Hh activity and observe equal result in vivo, by using genetic crosses between the Glis2 mut/mut and the Gli1 lacZ mouse. We report that, like other Gli proteins, Glis2 interacts with SuFu, which is an important regulator of the balance between Gli activators and repressors. Furthermore, we demonstrate that the fraction of Glis2 that is bound to SuFu is phosphorylated, whereas the immunoprecipitated Glis2-SuFu complex is subjected to ubiquitination, suggesting that the participation of Glis2 to the SuFu/Gli proteins complex (31,32) might be one of the mechanisms by which Glis2 affects the activity status of the pathway.
The data we have presented also indicate that, in the absence of Glis2, Hh activity abnormally persists in the kidney after the time at which the organ reaches full maturation and show that this point coincides with the peak of Glis2 transcription after birth. The coincidence is suggestive of an important role of Glis2 in regulating the transition between developing and mature kidneys, which are characterized by high and minimal Hh activity, respectively. The nearly absent Hh signaling in the adult kidneys could be one of the reasons why the status of the pathway after birth has been virtually unexplored and that loss-of-function mutations of the important Hh activator Gli2 do not result in kidney defects. On the other side, loss of function of Ptch1, a constitutive repressor of the pathway, results in the activation of Hh signaling. Embryos carrying homozygous Ptch1 mutations die in 
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Human Molecular Genetics, 2011, Vol. 20, No. 21 utero before the metanephro develops (33), but targeted inactivation of Ptch1 in the ureteric bud lineage results in renal hypoplasia secondary to ectopic activation of Hh signaling (7) . Conditional inactivation of Ptch1 after kidney development is fully reached would represent an appropriate model to verify whether withdrawal of Gli repression in a developed kidney results in the same phenotype displayed by the Glis2-knockout mice. The overall interpretation our results suggest that Glis2 would function by restricting Hh activity at baseline level, committing the kidney to a post-developmental state. A similar function is fulfilled by Glis2 in trigeminal ganglia, where it is necessary to promote the differentiation of postmitotic neurons from neural precursors (34), a process that is also controlled by Hh (35) . This hypothesis is also concordant with a model of Hh activity gradients that establish between cortex and medulla during kidney morphogenesis (7) and might explain why an overt kidney phenotype appears only later in life in mice and humans with loss of function mutations of Glis2.
Distinctive characteristics of the Hh pathway in vertebrates are the partial redundancy and the numerous physical and functional interactions that exist between many components of the pathway. An example of such complex interactions is the partial functional overlap that exists between Gli1 and Gli2: although homozygous inactivation of Gli2 results in severe multi-organ malformations, Gli1 null mutants do not have apparent phenotypes (36) (37) (38) , but they develop signs of Hh deficiency (partial loss of the floor plate) when a single allele of Gli2 is inactivated (39) . This and other evidences (16) indicate that Gli2 is the principal transcriptional regulator of Hh signaling. We think that this can explain why inactivating both Gli1 alleles in the Glis2 knockout does not rescue the Glis2 mut/mut phenotype and we only episodically observe partial recovery of Pax2 expression in Glis2;Gli1 double knockouts (data not shown). The mechanisms through which the abnormal Hh activation in the absence of Glis2 results in the development of kidney cysts and fibrosis are still unclear in their integrity, but they likely include the acquisition of mesenchymal phenotype by tubular epithelial cells, implying that Hh signaling could be one of the variables that control MET during nephrogenesis. Our data regarding the role of Glis2 in Hh regulation and the physical and functional interaction of Glis2 with genomic regulatory elements of Snai1 and Wnt4 suggest that the MET observed in the developing kidney could be achieved through Hh-dependent regulation of genes that master the transition from mesenchymal to epithelial phenotype (Snai1) or are necessary to govern this process at this stage of nephrogenesis (Wnt4 and Pax2). Wnt4 and Pax2 are required for tubule epithelialization, and their expression abruptly decreases after nephrogenesis is achieved. Our finding that loss of Glis2 is accompanied by unscheduled expression of these genes suggests that both are required at the stage of mesenchymal condensation to promote mesenchymal differentiation into epithelial structures, but are not necessary to maintain tubules in a differentiated state. The impaired development of the kidney observed in the absence of these genes in mice could be then ascribed to other functions, such as the control of cell survival of structures of the evolving nephron at this specific stage, which would secondarily result in a defect of tubulogenesis (40, 41) . Concordant with this reading are the observations that apoptosis is increased in Pax2-knockout mouse kidneys at this stage (40) , and that IMCD3 cells undergo apoptosis after siRNA-mediated suppression of Pax2 (41). Instead, Pax2 overactivity, which is what we observe in our mouse model, results in the development of microcysts involving the epithelial glomerular compartment (42) that resemble the phenotype observed in Glis2-knockout kidneys. It would be interesting to verify whether increased apoptosis at this stage can also be detected in Wnt4-knockout kidneys.
The last set of considerations that arise from our experiments regards the role of primary cilia in the pathogenesis of cystic kidney diseases. It has been widely documented that most of the genes that are defective in cystic kidney diseases encode for proteins that are localized to primary cilia of renal epithelial cells (43) . Similarly, disruption of Hh signaling, which, in vertebrates, is strongly dependent on cilia integrity has been repeatedly associated with cystic kidney phenotype (5, 44, 45) . Dysregulation of some Hh target genes that we have reported in our study has also been described in humans in association with other cystic kidney diseases, as in the case of the increased expression of Pax2 in biopsies of human subjects with NPHP (46) and autosomal dominant polycystic kidney disease (47) . This observation together with the results we have presented raises the possibility that misregulation of Hh signaling could be the common determinant that leads to the development of cystic kidney disease and fibrosis in diverse forms of ciliopathies. If studies on animal models of other known ciliopathies will confirm this hypothesis, our findings could open new avenues to the therapy of cystic kidney diseases, given the availability of numerous drugs that can modulate the Hh pathway.
MATERIALS AND METHODS
Cell cultures
HEK293T (ATCC CRL-11268), SHHN293T (48) (a kind gift from Lawrence Lum, PhD, UT Southwestern Medical Center, Dallas, TX, USA) and NIH-3T3 (ATCC CRL-1658) cells were cultured at 378C in DMEM high-glucose media (Fisher SH3002201), supplemented with 10% FBS (Fisher S11550) and 1% penicillin/streptomycin (Fisher SV30010). IMCD3 (NIH CRL-2123) cells were cultured at 378C in DMEM F-12 media (Fisher SH3002301) supplemented with 10% FBS and 1% penicillin/streptomycin. For the Hh stimulation experiments, both purified N-terminal Shh peptide (R&D Systems, 461-SH-025) at a final concentration of 50 mM and conditioned medium from HEK293T cells stably expressing N-Shh (49) were used. Since no difference was observed between the two, all experiments were replicated using conditioned media. GANT58 (Santa Cruz, sc-221723) was added to the cell culture medium at a final concentration of 10 nM.
Mice strains
Glis2
mut/mut mice were described somewhere else (18) . Gli1 lacZ mice (16) were purchased from The Jackson Laboratory (strain #008211).
Generation of anti-Glis2 antibodies
Since commercially available antibodies had not been effective in detecting Glis2 by western blot, we generated a polyclonal antibody against the C-terminus of Glis2 (TX747, Supplementary Material, Fig. S1 ). To minimize possible crossreactivity, the highly conserved Zn finger motif region was avoided in generating the antigen. A C-terminal (amino acids 318 to stop) fragment of Glis2 was cloned into 5 ′ -6His-tagged expression vectors (pHM6G, Addgene), expressed in BL21DE3 Escherichia coli cells and purified by affinity chromatography using a commercial resin (Qiagen NI-NTA AGAROSE 6-His Purification). Rabbits (Covance, Immunology Services, Denver, PA, USA) were injected with 5 mg of each peptide and serum was collected after 4 weeks. Immune sera and column affinity-purified antibodies were tested for different applications. Immunofluorescence IMCD3 cells were cultured to 80% confluence in standard conditions. The cells were then fixed for 15 min with a 4% paraformaldheyde (PFA) solution and permeabilized for 5 min with a 0.1% Triton X-100 in PBS. Cells were blocked for 1 h with 2% goat (Fisher NC9147657) or donkey serum (Sigma D9663), probed for 2 h with primary antibody, washed five times for 5 min with PBS and probed with a secondary antibody (Invitrogen Alexa Fluor) for 1 h. Cover slips were mounted using ProLong (Invitrogen P36931). Tissues were collected after perfusion with PBS and 4% PFA and then fixed in 4% PFA for 2 h on ice. After fixing, tissues
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Human Molecular Genetics, 2011, Vol. 20, No. 21 were left in a solution of 30% sucrose in PBS at 48C overnight, embedded in OCT compound and stored at 2808C. Tissue sections of 10 mm were air-dried for 30 min, rehydrated in PBS for 5 min, permeabilized in 0.1% Triton X-100 in PBS for 20 min and rinsed three times for 5 min in PBS. Sections were then incubated in a solution of 0.1% sodium borohydride (NaBH 4 ) for 30 min to quench autofluorescence. Sections were then rinsed with PBS and incubated in blocking solution (10% goat serum, 0.1%BSA in PBS) for 1 h at room temperature. The tissues were incubated overnight at 48C in primary antibody diluted in blocking solution. Sections were then washed with PBS and incubated in fluorescently labeled secondary antibody diluted 1:1000 in blocking solution for 1 h at room temperature, rinsed in PBS and mounted with ProLong. Images were acquired using a Zeiss LSM 510 confocal microscope.
X-gal staining
Frozen kidney sections were fixed for 10 min with 4% PFA in PBS, washed three times for 5 min with PBS and incubated overnight in a humidified chamber at 378C, in a solution of 1 mg/ml of X-gal. Slides were then rinsed with PBS followed by ddH 2 O, counterstained with eosin and mounted with Histomount (Invitrogen).
Live-cell imaging
IMCD3 and IMCD3-Glis2KD cells (8F) were grown under normal conditions on glass-bottom tissue culture dishes (Mattek). Live-cell imaging was performed using an incubation chamber attached to a Zeiss LSM 510 confocal microscope.
Immunofluorescence quantification and image processing
Images were acquired by immunofluorescence confocal microscopy and elaborated using ImageJ software (National Institutes of Health, Bethesda, MD, USA, http://rsb.info.nih. gov/ij/). Confocal microscopy acquisition parameters (pinhole, detector and amplifier gain, amplifier offset and filters) were set using reference samples and were kept constant in the acquisition of all the remaining images. Thirty-two bit single-channel images were converted to eight-bit and the total pixel intensity, on a 256 gray-scale level, was averaged to the number of pixels.
Lentiviral vector generation and cell infection
A set of five mmuGlis2-targeting shRNA plasmids for lentiviral infection was purchased from Open Biosystems (RMM4534-NM_031184). The plasmid pMD.2G, encoding the broad-range VSV-G envelope, and the psPAX2 packaging plasmid were a kind gift of Dr Woodring E. Wright from the Department of Cell Biology at UT Southwestern Medical Center, Dallas, TX, USA. Calcium phosphate was used to transfect the three plasmids into HEK293T cells. Beginning 48 h after transfection, the supernatant was collected every 24 h for three times. The three samples were pooled, centrifuged for 5 min at 1500 r.p.m. and cleaned through a 0.22 mm filter. IMCD3 cells were infected at a multiplicity of infection of 0.5-1 in the presence of polybrene (8 mg/ml, Sigma, cat. H9268), and puromycin (5 mg/ml, Fisher Scientific) was added to the medium after 24 h. Twenty stably transduced clones were isolated by limiting dilution and maintained in the medium supplemented with puromycin at 2 mg/ml for 10-14 days after the infection. All procedures were compliant with the UT Southwestern Medical Center biohazard procedures.
Doxycycline-inducible Glis2-targeting shRNA expression in IMCD3 cells
We utilized the 'all-in-one' tet-on shRNA expression plasmid pLKO-Tet-On (Addgene) as described (19) , to reverse the effect of Glis2 suppression in IMCD3 cells. The stuffer DNA was removed from pLKO-Tet-On by AgeI/EcoRI digestion and replaced with two annealed single-stranded complementary DNA oligos (oligo sequences in Supplementary Material, Table S2 ). Lentivirus packaging, IMCD3 cells infection and selection were performed as described above. ShRNA expression was induced by culturing cells in the presence of 100 ng/ml doxycycline (Clontech) for the reported intervals. RNAs of Glis2 and target genes' were quantified by quantitative PCR as described below. GFP-targeting oligos were used as a negative control.
Quantitative real-time PCR
Total RNA was isolated using TRIzol (Invitrogen) and purified with Qiagen RNeasy Mini Kit according to the manufacturer's protocols. First-strand reverse transcription reactions were performed on 1 mg of total RNA using the ThermoScript RT-PCR Kit (Invitrogen). Real-time PCR were performed using iQ SYBR Green Supermix (Bio-Rad). PCR primer sequences are listed in Supplementary Material 1. Specificity of each primer pair was validated by agarose gel electrophoresis and melting curve analysis. Amplification efficiency of all primer pairs was determined by standard curve analysis of reactions performed using serial substrate dilutions. Quantification of the enrichment of cis-acting genomic regions was evaluated by real-time PCR as described (50) . The experiments were performed on at least two independent ChIP samples and real-time PCR experiments were conducted in triplicates.
SDS -PAGE/western blotting
Protein concentrations were determined using a Pierce BCA Protein Assay Kit (PI-23225). Equal amounts of protein were mixed with 4× Laemmli sample buffer (Bio-Rad 161-0737) containing 100 mM DTT and denatured at 958C for 10 min. Samples were run on 10% polyacrylamide gels and transferred to PVDF membranes (LC2002). After transfer, blots were blocked in 5% BSA for 2 h at room temperature or overnight at 48C, probed with primary antibody in 1% BSA for 2 h at room temperature or overnight at 48C, and finally probed with secondary antibody in 1% BSA for 1 h at room temperature. Antibody binding was visualized with luminol reagent (Santa Cruz, sc-2048). When necessary, blots were 
Immunoprecipitation
Cells were lysed using 0.1% Triton X-100 (Fisher AC21568-0010). Protein concentration was determined with the Pierce BCA Protein Assay Kit, and 400 -600 mg of protein was used in each experiment. The lysates were pre-cleared with 50 ml of Protein A/G slurry (Santa Cruz SC-2003) for 1 h at 48C. After centrifugation, primary antibody was added to the supernatant and incubated overnight, rotating at 48C. One hundred microliters of protein A/G slurry was added and the samples were incubated for 1 additional hour. Beads were pelleted by centrifugation, supernatant was discarded and 2× Laemmli sample buffer containing 50 mM DTT was added to the pellet. Samples were heated at 958C for 10 min before being run on SDS -PAGE. For assaying the phosphorylation state of Glis2, immunoprecipitates were treated with 50 U of CIP for 3 h at 378C and loaded on gel in loading buffer.
Chromatin immunoprecipitation
About 5 × 10 6 wild-type IMCD3 cells and Glis2-knockdown cells (clones 8F and 7_2) were grown in 10 cm dishes. At roughly 90% confluence, the cells were rinsed with PBS and fixed with 1% formaldehyde for 10 min for crosslinking. Glycine was added to a final concentration of 125 mM for 5 min to stop the crosslinking reaction. Cells were then scraped from the dishes, spun at 2000g for 5 min and rinsed twice with PBS-containing protease inhibitors (PI). Cells were lysed in hypotonic buffer (5 mM PIPES, pH 8.0, 85 mM KCl, 0.5% NP-40, PI) on ice for 10 min and douncehomogenized. Lysates were centrifuged at 10 000g for 10 min to pellet the nuclear fraction. The pellet was rinsed twice with hypotonic buffer before nuclear lysis (30 min on ice in 1% SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 8.1, and PI). Lysates were sonicated with 8 -10 s pulses and debris centrifuged at 10 000g for 10 min. The supernatant was removed and diluted 1:10 with ChIP dilution buffer (1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-HCl, pH 8.1). Fifty microliters of protein A beads were added to preclear the lysates for 2 h at 48C. Beads were spun down and the supernatant was removed into a new tube and incubated overnight at 48C with 5 mg of anti-Glis2 TX747 antibody. Beads were spun down and washed as follows: 10 min with wash buffer 1 (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris -HCl, pH 8.1, 150 mM NaCl), 10 min with wash buffer 2 (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris -HCl, pH 8.1, 500 mM NaCl), 10 min with wash buffer 3 (0.25 M LiCl, 1% NP-40, 1% sodium deoxycholate, 1 mM EDTA, 10 mM Tris -HCl, pH 8.1) and two times 10 min with TE buffer. Protein-DNA complex was eluted incubating the beads in a 0.1% SDS, 0.1 M NaHCO 3 solution for 10 min at room temperature. Samples were then incubated in 300 mM NaCl at 658C overnight, digested with proteinase K (458C for 1 h) and the DNA was extracted in phenol chloroform and amplified by end-primed reaction (ChIP-Seq DNA Sample Prep Kit, Illumina).
Luciferase reporter assays
The effect of the Snai1 and Wnt4 5 ′ regulatory sequences on transcription was assayed using a dual-luciferase reporter system. The regulatory elements were amplified by PCR and cloned in pGL3-Basic (Promega, Inc.) upstream of the core promoter of each corresponding gene (Snai1 GBS: 25163 to 25057; Snai1 core promoter: 2358 to +50. Wnt4 GBS: 21098 to 2701; Wnt4 core promoter: 2700 to +40). The firefly luciferase gene was placed downstream of these cassettes and used as a reporter. IMCD3-Glis2KD cells were co-transfected with 600 ng of these plasmids and 50 ng of a plasmid expressing Renilla luciferase. Firefly activity was assayed 48 h after transfection using a Wallac VICTOR 2 Multilabel Reader and normalized to renilla activity.
Statistics and data analysis
Error bars report standard deviation (SD). Unpaired t-test was used for significance testing of all the experiments. All experiments were replicated at least three times unless otherwise specified.
